ArticleBMC pharmacology & toxicology2025

The real-world safety profile of empagliflozin: a disproportionality analysis based on the FDA Adverse Event Reporting System (FAERS) database.

Huiping Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.